» Articles » PMID: 35326052

Optical Coherence Tomography Features and Correlation of Functional and Structural Parameters in Patients of Idiopathic Intracranial Hypertension

Overview
Specialty Ophthalmology
Date 2022 Mar 25
PMID 35326052
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the correlation between functional parameters and optical coherence tomography (OCT) features in patients of idiopathic intracranial hypertension (IIH).

Methods: A prospective observational study in early and established cases of papilledema in IIH presenting from December 2017 to February 2019. Functional parameters (visual acuity, contrast sensitivity, mean deviation, VER, and MfERG) and structural parameters (RNFL, GCL-IPL, and optic disc height) were measured at baseline and every 6 weeks for 6 months.

Results: At baseline, average RNFL had a moderate negative correlation with mean deviation (r = -0.45; P = 0.0007) and a positive correlation with logMAR visual acuity (r = 0.18; P = 0.17). On the contrary, baseline GCL and logMAR visual acuity had a negative correlation (r = -0.4, P = 0.02). Optic disc height (ODH) had a negative correlation with visual field mean deviation (r = -0.046; P = 0.0005). At 6 months, ODH and GCL-IPL complex had a statistically significant correlation with functional parameters. However, RNFL values did not show any significant correlation with any of the functional parameters. Baseline GCL-IPL and optic disc height values had a moderate and significant correlation with final functional parameters. However, RNFL did not show any correlation with final functional parameters. Correlation between GCL-IPL thickness at 6 weeks and final functional parameters were stronger than that with baseline GCL values.

Conclusion: In the setting of severe papilledema, RNFL can misguide the prognosis. GCL-IPL can be a valuable tool for an objective evaluation of the integrity of the optic nerve in IIH and ODH may be used as an alternative or in combination with GCL-IPL in these cases.

Citing Articles

Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review.

Senthil M, Anand S, Chakraborty R, Bordon J, Constable P, Brown S J Neurol. 2024; 271(8):4769-4793.

PMID: 38856724 PMC: 11319609. DOI: 10.1007/s00415-024-12481-3.


Optical coherence tomography in papilledema: A probe into the intracranial pressure correlation.

Bassi S, Pamu R, Ambika S, Praveen S, Priyadarshini D, Dharini V Indian J Ophthalmol. 2024; 72(5):672-676.

PMID: 38189420 PMC: 11168544. DOI: 10.4103/IJO.IJO_1648_23.


Optic Nerve Head Changes Measured by Swept Source Optical Coherence Tomography and Angiography in Patients with Intracranial Hypertension.

Wang H, Cao L, Kwapong W, Liu G, Wang R, Liu J Ophthalmol Ther. 2023; 12(6):3295-3305.

PMID: 37792243 PMC: 10640446. DOI: 10.1007/s40123-023-00822-w.

References
1.
Savini G, Bellusci C, Carbonelli M, Zanini M, Carelli V, Sadun A . Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT. Arch Ophthalmol. 2006; 124(8):1111-7. DOI: 10.1001/archopht.124.8.1111. View

2.
Rebolleda G, Munoz-Negrete F . Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci. 2008; 50(11):5197-200. DOI: 10.1167/iovs.08-2528. View

3.
Huang-Link Y, Eleftheriou A, Yang G, Johansson J, Apostolou A, Link H . Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Eur J Neurol. 2018; 26(5):808-e57. DOI: 10.1111/ene.13893. View

4.
Kardon R . Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol. 2011; 31(4):353-61. PMC: 3226727. DOI: 10.1097/WNO.0b013e318238b9cb. View

5.
Waisbourd M, Leibovitch I, Goldenberg D, Kesler A . OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2011; 113(10):839-43. DOI: 10.1016/j.clineuro.2011.05.015. View